Category: Health Science
-
Beyond Boobs: Else Nutrition (BABY.V) is the plant-based baby formula alternative, and it’s a big deal
The scene: Late 2005, a run down pharmacy in East Vancouver. It’s early on a Sunday morning, raining heavily outside, and I haven’t slept for three days other than in half hour spurts, usually on the couch, or even on the floor. The reason? My newborn son is screaming. He’s hungry, but he’s chewed his…
-
A Closer Look: ThinkMyco pushes the button on magic mushroom market
Psilocybin and other psychedelics are forcing their way out of prohibition as potentially viable treatments for not only depression and anxiety but also Alzheimer’s and other neurodegenerative diseases plaguing millions in North America alone. In the end, psilocybin solutions address a $300 billion dollar psychotherapy and wellness global market. Shroom Stocks’ own Ethan Reyes spoke…
-
Cambridge House’s XFuture event spearheads brave new world of psychedelic treatments
Last minute attendees can register for Cambridge House’s Extraordinary Future event here and use promocode: FUTURE30 for 30% off. The Extraordinary Future Conference – running September 22-23, 2019 at the Vancouver Convention Center – helps investors find profitable positions in cutting edge science and tech companies. Sneek Peak: “Zen” Ken Kuiper earns his moniker with…
-
A ‘growing’ concern: With the cannabis bubble bursting, are mushrooms the next gold rush?
“Cannabis is dead; long live cannabis.” Mushrooms, mark my words.. –Ancient potstocks proverb Seriously though, folks, the cannabis sector is in trouble. Take a look at the Horizons Marijuana Life Sciences ETF, a basket of some of the largest cannabis stocks on the market. Here is equity.guru founder, Chris Parry’s take on how the growing pains of…
-
What the FDA thinks of Curaleaf (CURA.C), the ‘world’s largest cannabis co.’
On July 22, 2019, the U.S. Food and Drug Administration (FDA) sent a warning letter to Curaleaf Holdings (CURA.C) via overnight delivery. The message was plain: Four of the company’s CBD-infused products are “in violation of sections 505(a) and 301(d) of the Federal Food, Drug, and Cosmetic Act,” and Curaleaf’s CBD products for pets are “unapproved new…
-
VitalHub (VHI.V) sells patient-flow technology to Sudbury hospital
“I will love the day when nobody talks about blockchain and they just talk about the value creation,” stated IBM Blockchain GM Marie Wieck at the Brainstorm Finance conference in Montauk, N.Y. last week. Well said, Ms. Wieck. Let’s talk about value creation. On July 17, 2019, VitalHub (VHI.V) – a company that utilises blockchain…
-
ProMis Neurosciences (PMN.T) and the fight against Alzheimer’s
Someone in the world develops dementia every three seconds. Alzheimer’s disease and other dementia-related disorders affect 50M people around the world and that number is expected to double to 131.5M by 2050, that is, unless companies like ProMis Neurosciences (PMN.T) can do the unthinkable. See, our understanding of Alzheimer’s has changed dramatically since its discovery…
-
Experion Biotechnologies (VIR.V) starts telling its story, and you get the savings!
Jay Garnett from Experion Biotechnologies (VIR.V) has precisely zero f’s to give about building a million square feet of cannabis grow. He’s not buying a hemp farm in the Outer Hebrides, or a license application in Mongolia, or a mega greenhouse near the airport in Nunavut. He’s got a ten acre property in BC with…
-
Emerald Health (EMH.V) director stands down over security clearance issues
Buried in a news release discussing a shares-for-cash payment to an acquisition target, Emerald Health (EMH.V) stated Monday it is losing a board member over Health Canada security clearance concerns. Punit Dhillon is a self-described ‘life science thought leader‘ who likes to give TED Talks and has been involved with several biomedical companies on North…